首页|mRNA疫苗与脂质纳米颗粒递送载体的研究进展

mRNA疫苗与脂质纳米颗粒递送载体的研究进展

扫码查看
信使RNA(messenger,mRNA)是一类新兴的核酸药物,用于预防和治疗多种疾病.2020年,新型冠状病毒感染(coronavirus disease 2019,COVID-19)的大流行促进了历史上最快速的mRNA疫苗开发.2023年,Katalin Karikó及Drew Weissman获得诺贝尔生理学或医学奖,以表彰其发现核苷修饰,从而开发出有效的抗COVID-19 mRNA疫苗.这些无不凸显了mRNA技术在生命科学和医学研究方面的巨大潜力.尽管现在已经清楚mRNA疫苗可以快速、安全地保护患者免受传染病的侵害,但还需要进行更多研究来优化mRNA设计以及胞内递送.除了预防严重急性呼吸系统综合征冠状病毒2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)感染,多款mRNA疫苗也已经进入临床开发阶段,用于预防流感病毒、巨细胞病毒、寨卡病毒、呼吸道合胞病毒等病原体的感染.此外,多款针对肿瘤、罕见病的mRNA疫苗或药物也在加速研发.本文阐述了mRNA药物及疫苗的研发进展,并对部分代表性的mRNA药物或疫苗进行了总结;详细介绍了mRNA疫苗开发中的关键技术,包括mRNA的序列优化以及mRNA的工程化创新,总结了现如今最成熟的脂质纳米颗粒递送系统(lipid nanoparticle,LNP),并对mRNA-LNP疫苗的作用机制进行了详细的阐述.最后,对mRNA疫苗的前景和挑战提出了看法.
Progress on mRNA vaccines and lipid nanoparticles
Vaccines are one of the most remarkable achievements in the history of medicine and the most cost-effective and efficient way to prevent infectious diseases.By stimulating the immune system,vaccines enable the body to develop a defense mechanism against pathogens.The widespread adoption of vaccines has led to the eradication of the smallpox virus and a significant reduction in the global incidence of polio,measles,and other childhood diseases.Messenger RNA(mRNA)represents an emerging class of nucleic acid therapeutics employed for the prevention and treatment of diverse diseases.mRNA vaccines involve injecting mRNA carrying the encoded antigen protein into the human body,where it functions by translating the antigen protein within cells.This process triggers the production of specific immune responses,effectively achieving the goal of immunization and prevention.During the coronavirus disease 2019(COVID-19)pandemic,mRNA vaccines played a pivotal role,leading to an unprecedented rapid advancement in this technology.In 2023,Katalin Karikó and Drew Weissman were awarded the Nobel Prize in Physiology or Medicine for their groundbreaking discovery in nucleoside modifications.These achievements underscore the immense potential of mRNA technology in the fields of life science and medical research.Although mRNA vaccines have proven to be both effective and safe in preventing infectious diseases,further research is needed to optimize mRNA design and intracellular delivery.Beyond combating severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),numerous mRNA vaccines are in the development pipeline for various pathogens,including influenza virus,cytomegalovirus,Zika virus,and respiratory syncytial virus infections.Furthermore,there is a burgeoning momentum in the development of mRNA vaccines and drugs for tumors and rare diseases.This review provides an overview of the characteristics of mRNA drugs and vaccines,highlighting some representative mRNA drugs or vaccines.It delves into key technologies in mRNA vaccine development,such as sequence optimization and engineering innovations.Additionally,this review also discusses advanced lipid nanoparticle delivery systems and the mechanism of action of mRNA-LNP vaccines.Finally,the authors thoroughly examine the prospects and challenges associated with mRNA vaccines.

mRNA vaccinemRNA modificationmRNA deliveryLNP delivery system

樊渝川、殷涵、李钰、余溪、唐晓英、翁郁华、黄渊余

展开 >

北京理工大学生命学院,医学技术学院,前沿交叉科学研究院,分子医学与生物诊疗重点实验室,北京 100081

mRNA疫苗 mRNA修饰 mRNA递送 LNP递送系统

2024

科学通报
中国科学院国家自然科学基金委员会

科学通报

CSTPCD北大核心
影响因子:1.269
ISSN:0023-074X
年,卷(期):2024.69(33)